 |
The Journal of Neuroscience, March 28, 2007, 27(13):3571-3583; doi:10.1523/JNEUROSCI.0037-07.2007
Previous Article | Next Article 
Neurobiology of Disease
Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation
Jim P. Dompierre,1,2 *
Juliette D. Godin,1,2 *
Bénédicte C. Charrin,1,2
Fabrice P. Cordelières,1,2,3
Stephen J. King,4
Sandrine Humbert,1,2 and
Frédéric Saudou1,2,3
1Institut Curie, 2Centre National de la Recherche Scientifique Unité Mixte de Recherche 146, and 3Plate-forme Imagerie Cellulaire et Tissulaire, F-91405 Orsay, France, and 4Division of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri-Kansas City, Kansas City, Missouri 64110
Correspondence should be addressed to either of the following: Sandrine Humbert, Institut Curie, Unité Mixte de Recherche (UMR) 146, F-91405 Orsay, France, Email: Sandrine.Humbert{at}curie.u-psud.fr; or Frederic Saudou, Institut Curie, UMR 146, F-91405 Orsay, France, Email: Frederic.Saudou{at}curie.u-psud.fr
A defect in microtubule (MT)-based transport contributes to the neuronal toxicity observed in Huntington's disease (HD). Histone deacetylase (HDAC) inhibitors show neuroprotective effects in this devastating neurodegenerative disorder. We report here that HDAC inhibitors, including trichostatin A (TSA), increase vesicular transport of brain-derived neurotrophic factor (BDNF) by inhibiting HDAC6, thereby increasing acetylation at lysine 40 of -tubulin. MT acetylation in vitro and in cells causes the recruitment of the molecular motors dynein and kinesin-1 to MTs. In neurons, acetylation at lysine 40 of -tubulin increases the flux of vesicles and the subsequent release of BDNF. We show that tubulin acetylation is reduced in HD brains and that TSA compensates for the transport- and release-defect phenotypes that are observed in disease. Our findings reveal that HDAC6 inhibition and acetylation at lysine 40 of -tubulin may be therapeutic targets of interest in disorders such as HD in which intracellular transport is altered.
Key words: Huntington's disease; polyglutamine; transport; microtubules; BDNF; neuroprotection
Received Jan. 5, 2007;
revised Feb. 19, 2007;
accepted Feb. 22, 2007.
Correspondence should be addressed to either of the following: Sandrine Humbert, Institut Curie, Unité Mixte de Recherche (UMR) 146, F-91405 Orsay, France, Email: Sandrine.Humbert{at}curie.u-psud.fr; or Frederic Saudou, Institut Curie, UMR 146, F-91405 Orsay, France, Email: Frederic.Saudou{at}curie.u-psud.fr
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Patel, K. H. Fisher, E. C. C. Yang, C. M. Deane, and R. E. Harrison
Proteomic Analysis of Microtubule-associated Proteins during Macrophage Activation
Mol. Cell. Proteomics,
November 1, 2009;
8(11):
2500 - 2514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zilberman, C. Ballestrem, L. Carramusa, R. Mazitschek, S. Khochbin, and A. Bershadsky
Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6
J. Cell Sci.,
October 1, 2009;
122(19):
3531 - 3541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hazama, X. Qu, K. Yokoyama, C. Tanaka, E. Kinoshita, J. He, S. Takahashi, K. Tohyama, H. Yamamura, and Y. Tohyama
ATP-induced osteoclast function: the formation of sealing-zone like structure and the secretion of lytic granules via microtubule-deacetylation under the control of Syk
Genes Cells,
July 1, 2009;
14(7):
871 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chang, R. H. Baloh, and J. Milbrandt
The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons
J. Cell Sci.,
July 1, 2009;
122(13):
2274 - 2282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Reiner, A. Shmueli, and T. Sapir
Neuronal Migration and Neurodegeneration: 2 Sides of the Same Coin
Cereb Cortex,
July 1, 2009;
19(suppl_1):
i42 - i48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gardiner, D. Barton, R. Overall, and J. Marc
Neurotrophic Support and Oxidative Stress: Converging Effects in the Normal and Diseased Nervous System
Neuroscientist,
February 1, 2009;
15(1):
47 - 61.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Dhakal and M. A. Mulvey
Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway
J. Biol. Chem.,
January 2, 2009;
284(1):
446 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Geiger, C. D. Kaufman, A. P. Lam, G. R. S. Budinger, and D. A. Dean
Tubulin Acetylation and Histone Deacetylase 6 Activity in the Lung under Cyclic Load
Am. J. Respir. Cell Mol. Biol.,
January 1, 2009;
40(1):
76 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zala, E. Colin, H. Rangone, G. Liot, S. Humbert, and F. Saudou
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
Hum. Mol. Genet.,
December 15, 2008;
17(24):
3837 - 3846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Jiang, Y. Ren, and J. Feng
Direct Binding with Histone Deacetylase 6 Mediates the Reversible Recruitment of Parkin to the Centrosome
J. Neurosci.,
November 26, 2008;
28(48):
12993 - 13002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hirokawa and Y. Noda
Intracellular Transport and Kinesin Superfamily Proteins, KIFs: Structure, Function, and Dynamics
Physiol Rev,
July 1, 2008;
88(3):
1089 - 1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Barrett and M. A. Wood
Beyond transcription factors: The role of chromatin modifying enzymes in regulating transcription required for memory
Learn. Mem.,
June 26, 2008;
15(7):
460 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Outeiro, E. Kontopoulos, S. M. Altmann, I. Kufareva, K. E. Strathearn, A. M. Amore, C. B. Volk, M. M. Maxwell, J.-C. Rochet, P. J. McLean, et al.
Sirtuin 2 Inhibitors Rescue {alpha}-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
Science,
July 27, 2007;
317(5837):
516 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|